We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$69.3B
AUM Growth
+$9.18B
Cap. Flow
+$3.47B
Cap. Flow %
5.01%
Top 10 Hldgs %
26.5%
Holding
3,740
New
311
Increased
1,893
Reduced
1,169
Closed
273

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$261M
2
MSFT icon
Microsoft
MSFT
+$169M
3
GEV icon
GE Vernova
GEV
+$143M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$107M
5
JPM icon
JPMorgan Chase
JPM
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 20.78%
2 Financials 8.14%
3 Consumer Discretionary 5.23%
4 Healthcare 4.75%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPT icon
3376
ChargePoint
CHPT
$133M
$30.3K ﹤0.01%
2,156
+473
+28% +$6.34K
SANA icon
3377
Sana Biotechnology
SANA
$885M
$30.2K ﹤0.01%
+11,045
New +$22.8K
ACRS icon
3378
Aclaris Therapeutics
ACRS
$730M
$29.8K ﹤0.01%
21,010
-16,959
-45% -$22.9K
LOT icon
3379
Lotus Technology
LOT
$566M
$28.8K ﹤0.01%
13,098
-91,443
-87% -$171K
EGHT icon
3380
8x8 Inc
EGHT
$247M
$27.6K ﹤0.01%
+14,088
New +$24.9K
GETY icon
3381
Getty Images
GETY
$184M
$27.5K ﹤0.01%
+16,538
New +$29.1K
MRM
3382
MEDIROM Healthcare Technologies
MRM
$7.79M
$27K ﹤0.01%
+19,000
New +$21K
VTYX
3383
DELISTED
Ventyx Biosciences
VTYX
$26.7K ﹤0.01%
12,468
-4,387
-26% -$7.08K
ABSI icon
3384
Absci
ABSI
$1.28B
$26.6K ﹤0.01%
10,360
-15,375
-60% -$43.3K
OESX icon
3385
Orion Energy Systems
OESX
$41.1M
$26.6K ﹤0.01%
4,353
IPW icon
3386
iPower
IPW
$1.27M
$26.4K ﹤0.01%
170
CHGG icon
3387
Chegg
CHGG
$108M
$26.2K ﹤0.01%
21,648
+6,071
+39% +$5.61K
ABAT icon
3388
American Battery Technology Co
ABAT
$301M
$26K ﹤0.01%
+16,058
New +$20.8K
EXFY icon
3389
Expensify
EXFY
$166M
$25.9K ﹤0.01%
10,008
RDZN icon
3390
Roadzen
RDZN
$101M
$25.8K ﹤0.01%
26,318
-100,747
-79% -$101K
TNYA icon
3391
Tenaya Therapeutics
TNYA
$168M
$25.3K ﹤0.01%
41,418
+16,374
+65% +$8.33K
NUVB icon
3392
Nuvation Bio
NUVB
$2.24B
$25.2K ﹤0.01%
+12,944
New +$27K
INMB icon
3393
INmune Bio
INMB
$43.1M
$25.1K ﹤0.01%
+10,879
New +$79.8K
OXSQ icon
3394
Oxford Square Capital
OXSQ
$151M
$24.9K ﹤0.01%
11,172
+661
+6% +$1.58K
TCRX icon
3395
TScan Therapeutics
TCRX
$51.9M
$24.7K ﹤0.01%
17,054
+2,474
+17% +$3.57K
REFR icon
3396
Research Frontiers
REFR
$16.1M
$24.6K ﹤0.01%
+15,000
New +$22K
LAR
3397
Lithium Argentina AG
LAR
$958M
$24.5K ﹤0.01%
+11,774
New +$23.4K
BFLY icon
3398
Butterfly Network
BFLY
$1.72B
$24K ﹤0.01%
12,000
-11,732
-49% -$26.9K
BTBT icon
3399
Bit Digital
BTBT
$484M
$23.9K ﹤0.01%
+10,902
New +$24.1K
MRNY icon
3400
YieldMax MRNA Option Income Strategy ETF
MRNY
$98.4M
$23.5K ﹤0.01%
+1,000
New +$24.6K

Similar funds

Mariner's Q2 2025 Portfolio in Review

As of Q2 2025, Mariner held 3,740 positions worth $69.3B, up 15% from $60.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mariner deployed $3.47B of net new capital in Q2 2025, opening 311 new positions and adding to 1,893 existing holdings. Its largest new stake was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Union Pacific, an estimated $83.9M trimmed.

  • Mariner's largest Q2 2025 buy was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.
  • Mariner added most to Apple in Q2 2025, an estimated $261M increase.
  • Mariner's biggest Q2 2025 reduction was Union Pacific, cutting an estimated $83.9M.
  • Mariner fully exited Discover Financial Services in Q2 2025, selling an estimated $7.86M.
  • Mariner's ten largest holdings make up 26% of its $69.3B portfolio in Q2 2025.
  • Mariner opened 311 new positions and closed 273 in Q2 2025.
  • Mariner's portfolio value rose 15% quarter-over-quarter to $69.3B.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.